Metraipolis › archive › dc_bd59371db8cf

Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy:… — Europe PMC PMID:41179288

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41179288
DOI
10.32604/or.2025.068609
License (as archived)
solo-consultazione
Archived
2026-11-09T03:56:52.054Z
SHA-256 of the archived text
a639b8ae6f4a6c4cb20a6dbbaf0aa047ac2b06829cf938b46f8fb4f6987385cd
Stable URL of this page
https://metraipolis.com/documento/dc_bd59371db8cf

How to cite

Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy:… — Europe PMC PMID:41179288 — Europe PMC (en), https://europepmc.org/article/MED/41179288 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd59371db8cf (Metraipolis archive dc_bd59371db8cf, sha256 a639b8ae6f4a6c4cb20a6dbbaf0aa047ac2b06829cf938b46f8fb4f6987385cd)
BibTeX
@misc{dcbd59371db8cf,
  title = {Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy:… — Europe PMC PMID:41179288},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41179288},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd59371db8cf; sha256 a639b8ae6f4a6c4cb20a6dbbaf0aa047ac2b06829cf938b46f8fb4f6987385cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41179288. Agents can read the archived copy with the MCP tool read_document.